Compound Management Market : Size Estimation And Analysis Of Wide Range Of Growth Opportunities For Industry Players

 [118 Pages Report] The Compound management market is projected to reach USD 424.5 million in 2023 from USD 215.3 million in 2018, at a CAGR of 14.5% during the forecast period.

The growth of the market can be attributed to increasing drug discovery activities, the growing biopharmaceutical industry, and the rising trend in outsourcing compound/sample management.

Market Dynamics

• Increasing Drug Discovery Activity
• Growth of the Biopharmaceutical Industry
• Rising Outsourcing of Compound/Sample Management
• Growth of the Biobanking Sector

“By sample type, the chemical compounds segment to account for the largest share during the forecast period.”

The rising drug discovery activity is leading to an increased demand for compounds, which is positively affecting market growth.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182172928  

The outsourcing services segment is projected to register the highest CAGR during the forecast period. This high growth is due to the shift in trend towards outsourcing compound management to third-party service providers. These companies are experts in compound management and provide various services to pharmaceuticals, biopharmaceuticals, and CROs with regard to their compound storage needs, and are reasonably priced.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East and Africa

The large share of North America is attributed to the presence of the large pharmaceutical and biopharma industry. As a result, several companies in North America are engaged in drug discovery activities, which require the maintenance of substantial chemical libraries. Moreover, to maintain the productivity of such innovative drugs and biologics, most of the leading pharma and biopharma companies have started building compound management facilities or contracting external service providers.

Some key players mentioned in the research report are:

Brooks Automation (US), Hamilton Company (US), TTP Group (US), Labcyte (US), Biosero (US)

Request for sample pages @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=182172928 

Transfer Membrane Market Worth USD 187.9 Million : Indicates Impressive Growth Rate In Pharmaceuticals Industry

 According to the new market research report “ Transfer Membrane Market According to the new market research report “ Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry, Dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies)”, published by MarketsandMarkets™,transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.

Expected Revenue Growth:

The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.

Major Growth Drivers:

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.

Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of market.

The report analyzes the global market by type, transfer method, application, end user, and region.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36975865

This report covers the market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global transfer membrane market in 2018, followed by Europe. The large share in the North American region is mainly attributed to the presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and high target disease prevalence in the region.

Key Market Players

Thermo Fisher Scientific (US) held the second leadership position in the global market. Other prominent players in the global market included PerkinElmer (US), , Bio-Rad Laboratories (US), GE Healthcare (US), Pall Coporation (US), Advansta (US), GVS (OTCPK), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India),.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=36975865

Transplant Diagnostics Market Worth USD 5.5 Billion – Current Status, Growth Dynamics And Future Trends

 According to the new market research report ”Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) – Global Forecast to 2025“, published by MarketsandMarkets™, transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.

Major Growth Drivers:

The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

Expected Revenue Growth:

[227 Pages Report] The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.

An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the market. Product launches were the most widely adopted growth strategies.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061  

The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019

The market, by technology, is segmented into molecular and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the market. The large share of this segment can be attributed to the benefits offered by molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis.

North America accounted for the largest share of the market in 2019

North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics are the major factors driving the market in North America.

Request for sample pages :   https://www.marketsandmarkets.com/requestsampleNew.asp?id=2531061  

Key Market Players

Some of the players in the transplant diagnostics market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), bioMérieux SA (France), Immucor, Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Hologic, Inc. (US).

Drug Screening Market : Future Of Chromatography, It Is Creating Real Change In The Rapid Testing Devices Industry

 According to the new market research report ” Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) – Global Forecast to 2025″, published by MarketsandMarkets™ , global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

Major Growth Drivers:

Growth in this market is attributed to the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches.

Expected Revenue Growth:

[192 Pages Report] The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

COVID-19 impact on the drug screening market

COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures.

Browse in-depth TOC on “Drug Screening Market”192 – Tables35 – Figures192 – Pages

Download PDF Brochure: Drug Screening Market

The rapid testing devices segment will witness the highest growth during the forecast period.

Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2019. However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.

North America was the largest regional market for drug screening market in 2019.

The drug screening market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.

Request for sample pages : Drug Screening Market

Key Market Players

The prominent players operating in this market include LabCorp (US), Quest Diagnostics (US), Alere (US), OraSure (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).

Synthetic Biology Market To Reach USD 30.7 Billion By 2026 – Scope In Gene Synthesis

According to the new market research report “Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Gene Synthesis, Genome Engineering), Application (Tissue Regeneration, Biofuel, Consumer Care, Food & Agriculture, Environmental) and Region – Global Forecast to 2026″, published by MarketsandMarkets™, the global market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period.

Browse in-depth TOC on “Synthetic Biology Market”452 – Tables39 – Figures377 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

COVID-19 impact on the synthetic biology market

Many established pharmaceutical and biopharmaceutical companies, along with players of the synthetic biology market, have stepped forward to contribute to worldwide research efforts by providing synthetic biology for developing test kits, treatments, and vaccines to target the infection caused by the coronavirus. Synthetic biology is highlighted as one of the emerging technologies in a report from the European Parliament. It can fight the COVID-19 pandemic. The National Institute of Health in the US has also identified synthetic biology as one way to speed up vaccine development.

The medical applications segment accounted for the largest share of the application segment in the market in 2020.

Based on application, the market is categorized into three segments—medical applications, industrial applications, food & agriculture, and environmental applications. In 2020, medical applications segment accounted for the largest share of synthetic biology market. Factors such as the extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies, is the primary driver for the medical segment’s growth.

Request for sample pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

The Asia Pacific region is the fastest-growing region of the synthetic biology market in2020.

The Asia Pacific region is estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such the growing collaborations in the field of synthetic biology, growing partnerships in the Chinese market, and investments in Asia Pacific countries for research.

IV Equipment Market – By 2022, Global Industry Is Expecting To Grow At CAGR Of 6.2%

 Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Presently, many companies are developing various infusion devices capable of being integrated with alarm devices, monitoring devices, and data exchange systems.  

[166 Pages Report] The overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.

The global burden of chronic diseases such as heart disease, stroke, cancer, chronic respiratory diseases, and diabetes is increasing rapidly. According to the World Health Organization (WHO) 2015, chronic diseases accounted for approximately 60% of the total reported deaths in the world. The proportion of the burden of chronic diseases (chronic non-communicable diseases) is expected to increase to 57% by 2020 from 46% in 2001.

Market Dynamics

1. Low Prices of Reprocessed Medical Devices2. Pressure to Reduce Volume of Regulated Medical Waste

Increasing incidence of chronic diseases and rising geriatric population, growing number of surgical procedures performed, rising demand for ambulatory infusion pumps due to the growing home care market, rising number of needlestick injuries and infections are the key factors driving the growth of this market

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313 

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Middle East and Africa5. Latin America

The IV equipment market in APAC is expected to grow at the highest CAGR during the forecast period. The demand for IV equipment and accessories in the APAC region is majorly driven by factors such as the large population base in the region, rising geriatric population, rising incidence of chronic diseases, improving accessibility to advanced healthcare facilities, rising healthcare spending, growing penetration of health insurance, increasing demand for advanced technologies, growing investments in emerging APAC countries by key market players, and expansion of private-sector hospitals to rural areas.

Some key players mentioned in the research report are:

Some of the prominent players in the global IV equipment market are Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter Interanl Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), Smiths Medical (U.K.), C. R. Bard, Inc. (U.S.), Terumo Corporation (Japan), Moog, Inc. (U.S.), and AngioDynamics, Inc. (U.S.). These players adopted both organic as well as inorganic strategies such as product launches and enhancements, collaborations and agreements, acquisitions and grant to sustain in this market.

Analytical Laboratory Services Market Worth $ 333.8 Million – Technological advancements in the field of analytical testing

 The key trends for increase in market, by public health organization are the growing expenditure on drugs and medical devices by public health organizations, steps by the government to build up strong analytical testing abilities, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical testing services. 

[68 Pages Report] The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period.

The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services. 

Market Dynamics

• Growing Expenditure on Drugs and Medical Devices By Public Organizations
• Government Initiatives to Strengthen Analytical Testing Capabilities
• Increasing Number of Drug Approvals and Clinical Trials
• Rising Demand for Specialized Analytical Testing Services

On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65590498

This growth can be attributed to factors such as the usage and development of a large number of macromolecules and Biosimilars for various therapeutic areas and the growing biopharmaceutical industry across the globe. The spending on batch release testing services is expected to account for the second largest share during the forecast period.

The geographical regions mapped in the report are:

Geographically, the market, by public health organization is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. The major share of this region can be attributed to the high expenditure on quality testing, strong regulatory scenario, increasing number of clinical trials, and the well-established federal testing laboratories in the region. Moreover, Asia-Pacific is expected to grow at the highest CAGR during the forecast period.

Request for sample pages  @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=65590498

Some key players mentioned in the research report are:

Food and Drug Administration (U.S.), European Medicines Agency (U.K.), Federal Institute for Drugs and Medical Devices (Germany), Agence française de sécurité sanitaire des produits de santé (France), Agenzia Italiana del Farmaco (OTCPK:ITALY), the Spanish Medicines and Health Products Agency (Spain), Central Drugs Standard Control Organization (India), China Food and Drug Administration, and Pharmaceuticals and Medical Devices Agency (Japan).

Healthcare BPO Market worth USD 468.5 billion by 2026 : Analysis Of Worldwide Industry Trends And Opportunities

 Healthcare business process outsourcing allows healthcare facilities to contract their non-core activities to an external party and focus on their core competencies. Growth of this market is attributed to the growing outsourcing in the pharma and biopharma industries, need to curtail the escalating healthcare costs, rising demand for niche services (including care management and fraud detection services), and the need for structured processes and documentation in the healthcare industry.

What the Market Looks Like?

[309 Pages Report] The global healthcare BPO market is projected to reach USD 468.5 billion by 2026 from USD 296.4 billion in 2021, at a CAGR of 9.6% during the forecast period. North America dominated the healthcare BPO market, with a share of 49.0% in 2021, followed by Europe (30.6%) and the RoW (20.3%)

Cost savings form an important consideration in outsourcing, as by doing so, companies can reduce costs on resource management, labor, and space. There is pressure on the margins of healthcare payers due to the rise of health insurance exchanges (online marketplaces to obtain health insurance from competing providers) in the US. This enables consumers to obtain coverage from competing private healthcare providers and is likely to accelerate the adoption of outsourcing to rationalize costs.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=472

COVID-19 Impact on the Healthcare BPO Market

The COVID-19 pandemic has had a significant impact on the world’s population and economy. As a result of the pandemic, healthcare facilities are facing immense pressure to create a well-coordinated environment where all clinical functions are connected internally and where the organization operates in coordination with other healthcare units. This is compelling healthcare organizations to outsource their non-core functions, including revenue cycle management, claims management, and patient engagement, among other functions, to third parties and focus on their core competencies for better patient outcomes. The impact of COVID-19 on the healthcare BPO industry is complicated as well as multi-faceted.

What are Key Trends in the Market?

The growth of the High Content Screening Market is primarily influenced by the following factors:

1. Shift to ICD-10 coding standards and upcoming ICD-11 standards
2. Pressure to reduce the rising healthcare costs
3. Loss of revenue due to billing errors
4. Demand for niche services
5. Need for structured processes and documentation
6. Lack of in-house expertise in end-use industries

Artificial intelligence and machine learning, in particular, make the drug discovery process more efficient and substantially improve success rates at the early stages of drug development. This will help healthcare BPO service providers to bring about major breakthroughs, as artificial intelligence also plays an important role in the discovery of drugs for chronic diseases such as cancer. Owing to its capabilities, AI significantly reduces the time taken to bring a cancer-combatting drug to the market, which will lead to significant growth in the healthcare BPO services market.

Read more about Healthcare BPO Market
@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=472

3D Printing Medical Devices Market By Type, End-Use Industry, And Region - Global Forecast To 2026 (At A CAGR Of 16.3%)

 [497 Pages Report] The 3D Printing Medical Devices market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period

Market Dynamics

• Technological Advancements in 3D Printing
• Increasing Public-Private Funding for 3D Printing Activitiesrials
• Easy Development of Customized Medical Products Using 3D Printing
• Growing Applications of 3D Printing in the Healthcare Industry

In recent years, there has been a significant increase in public-private funding to support various initiatives in the 3D printing industry. Such research and funding activities are expected to boost the development of 3D printing products and technologies, thereby driving the growth of the 3D printing medical devices market.

Download PDF Brochure @   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90799911 

The digitization of dentistry and medical procedures has advanced immensely over the years, with the intention of improving the clinical workflow through the incorporation of technology. The industry is experiencing a shift from traditional to digital dentistry and surgeries. Direct digital manufacturing involves the application of computer-controlled processes for developing a physical object directly from a digital design. With advancements in 3D printing, direct digital manufacturing is becoming a widely used technology as compared to traditional manufacturing techniques.

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. RoW
5. Latin America
6. Middle East & Africa

The report covers the 3D Printing Medical Devices market across five major geographies, namely, Europe, North America, Asia Pacific, Latin America, and MEA. North America commanded the largest share of the 3D Printing Medical Devices market in 2020. Market growth is mainly attributed to the strong base of healthcare facilities, especially hospitals and diagnostic imaging centers, and the growing installation base for 3D printer in healthcare facilities.

Some key players mentioned in the research report are:

Stratasys Ltd. (US & Israel), 3D Systems Corporation (US), GE Additive (US), Materialise NV (Belgium), Renishaw plc (UK), SLM Solutions Group AG (Germany), Desktop Metal, Inc. (US), Prodways Group (France), Carbon, Inc. (US), CELLINK (Sweden), Organovo Holdings, Inc. (US), EOS (Electro Optical Systems) GmbH (Germany), Biomedical Modeling, Inc. (US), Formlabs, Inc. (US), 3T Additive Manufacturing Ltd. (UK), DENTSPLY Sirona, Inc. (US), DWS Systems SRL (OTCPK:ITALY), Roland DG (Japan), HP, Inc. (US), and regenHU (Switzerland) among others.

Request for sample pages @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=90799911 

Aesthetic Lasers Market Worth USD 1,132.7 Million By Type, End-Use Industry, And Region – Global Forecast To 2021

 This study estimates the market size for 2016 and projects its demand till 2021. Primary and secondary research was used to for market estimation and forecast. Various secondary sources such as directories, industry journals, and databases have been used to identify and collect information useful for this extensive commercial study of the market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the market.

The global aesthetic lasers market is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021.

Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rise in medical tourism devices are the major factors driving the growth of the aesthetic lasers market. However, the rising adoption of energy-based devices and low focus of market players on aesthetic/cosmetic devices are restraining the growth of this market.

Market Dynamics

• Growing Adoption of Non-Invasive Aesthetic Procedures
• Changing Lifestyle and Growing Disposable Income
• Technological Advancements
• Growing Medical Tourism

The aesthetic lasers market is segmented on the basis of type, application, end user, and region. On the basis of type, the market is segmented into standalone lasers and multiplatform lasers. Standalone lasers are further segmented into carbon dioxide (CO2) lasers, erbium YAG lasers, diode lasers, pulsed dye lasers, Nd:YAG lasers, alexandrite lasers, other standalone lasers (argon, ruby, krypton lasers, and erbium:glass lasers). Standalone lasers have advantages such as simplicity of functioning and ease of use which has significantly boosted their adoption and accounts for the highest market share of the aesthetic lasers market in 2016.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94673613

Based on type, the aesthetic/cosmetic lasers type market is segmented into standalone lasers and multiplatform lasers. In this market, multiplatform lasers formed the fastest-growing segment as they provide scalable and upgradeable hybrid systems that can treat multiple indications. Factors such as multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication is contributing to the high growth of this segment in the forecast period.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Rest of the World (RoW)

The market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Among these regional segments, North America is expected to account for the largest share of the global aesthetic lasers market. However, the Asia-pacific is expected to grow at the highest CAGR during the forecast period. The high growth in this regional segment can be attributed to factors changing lifestyles, rising incidences of skin damage, and increasing medical tourism in the region will drive the growth of this market..

Request for sample pages  @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=94673613

Some key players mentioned in the research report are:

Industry trends such as social media marketing and increasing consolidations of manufacturers and suppliers of aesthetic lasers products is further driving the growth of this market. Major players in the aesthetic lasers market include Aerolase (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), El.En. SpA (OTCPK:ITALY), Lumenis Ltd. (Israel), Sciton, Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Inc. (Israel), and Solta Medical (U.S.).

Inspection Machines Market By Type, End-Use Industry, And Region – Global Forecast To 2025 (At A CAGR Of 5.4 %)

 The Inspection machines market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period.

The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP).

Market Dynamics

• Growing number of regulatory mandates to maintain compliance with GMP in the healthcare industry
• Increasing pharmaceutical & biotechnology R&D expenditure
• Growing product recalls
• The increasing number of inspection checkpoints throughout the production line
• Growth in the medical devices industry

The increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085 

COVID-19 Impact on Global Inspection Machines Market

Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the inspection machines market, temporarily leading to a fall in demand due to uncertainty in the global economy and capital markets.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East and Africa (MEA)

In 2019, North America accounted for the largest share of the inspection machines market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the significant growth opportunities for players operating in the inspection machines market owing to the presence of a large number of pharmaceutical and biotechnology companies & medical device manufacturers in the region, stringent regulatory mandates for healthcare manufacturers, an increasing number of inspection checkpoints in the production line, and highly regulated inspection standards & obligatory compliance in the region.

Request for sample pages  @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=81453085 

Some key players mentioned in the research report are:

The top market players in the global inspection machines market include Thermo Fisher Scientific (US), Robert Bosch GmbH (Germany), OPTEL Group (Canada), Körber AG (Germany), Cognex Corporation (US), METTLER-TOLEDO International Inc. (US), Teledyne Technologies Incorporated (US), ACG Group (India), OMRON Corporation (Japan), Antares Vision S.p.A. (OTCPK:ITALY), Brevetti CEA SpA (OTCPK:ITALY), Jekson Vision Private Limited (India), Mitsubishi Chemical Holdings Corporation (Japan) 

Laboratory Filtration Market By Type, End-Use Industry, And Region – Global Forecast To 2025

Growth in this market is driven majorly by the rising R&D spending in the pharmaceutical & biopharmaceutical industry, growing demand for membrane filtration technology, increasing purity requirements in end-user segments, and growing focus on developing large-molecule biopharmaceuticals. However, the high cost of systems is expected to restrain the growth of the lab filtration market to a certain extent during the forecast period.

[221 Pages Report] The global laboratory filtration market size is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3% during the forecast period.

Market Dynamics

• Rising R&D Spending in the Pharmaceutical & Biopharmaceutical Industry
• Growing Demand for Membrane Filtration Technology
• Increasing Purity Requirements in End-User Segments
• Focus on Developing Large-Molecule Biopharmaceuticals

The increasing adoption of automated inspection systems in the pharmaceutical and biotechnology industries, growth in the number of product recalls, an increasing number of inspection checkpoints throughout the production line, and technological advancements in inspection systems support the growth of the market.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082 

Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories). The filtration media segment accounted for the largest market share in 2018.

The geographical regions mapped in the report are:

The global lab filtration market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth of the market in North America is mainly driven by the large number of pharmaceutical & biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and the stringent regulatory scenario in the pharmaceutical industry.

Request for sample pages @   https://www.marketsandmarkets.com/requestsampleNew.asp?id=12936082 

Some key players mentioned in the research report are:

The prominent players in the global lab filtration market are Merck Millipore (US), Danaher Corporation (US), Sartorius Ag (Germany), 3M Company (US), GE Healthcare (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Cantel Medical Corporation (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc (US) 

Vaccine Adjuvants Market : Global Analysis, Opportunities And Forecast 2021

 The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants.

Download PDF Brochure :   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894 

Global Vaccine Adjuvants Market Segmentation:

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

+ On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016.

+ On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.

What Drives the Market?

1. Increasing Use of Adjuvants in Vaccine
2. High Prevalence of Infectious and Zoonotic Diseases
3. Increase in Livestock and Instances of Diseases4. Increasing Focus on Immunization Programs From Various Government Bodies
5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants
6. Increasing Focus and Support on the Discovery and Development of Vaccine Adjuvants
7. Increasing Geriatric Population

Geographical Growth Analysis:

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.

Request for sample pages  : https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Intraoperative Radiation Therapy Market Worth USD 66 Million : Improving Reimbursement Scenario

 [159 Pages Report] The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.

The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.

Market Dynamics

• Growing global prevalence of cancer
• Improving reimbursement scenario
• Procedural advantages over EBRT
• Technological advancements

COVID-19 Impact on the global Intraoperative radiation therapy market

The intraoperative radiation therapy market was significantly impacted by the COVID-19 pandemic. Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market. The pandemic also impacted the availability of healthcare resources. Major regulatory authorities across the globe, such as the CDC, WHO, MHRA, TGA, and EMA, have identified cancer patients at a greater risk of contracting coronavirus disease than healthy adults.  

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083

The IORT procedure is associated with various advantages such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure of normal tissue. This is especially true for breast cancer, as this mode offers women a choice of breast-sparing treatment (lumpectomy). The increasing prevalence of breast cancer is, therefore, a key factor driving the market growth. The growing prevalence of cancer will increase the adoption of IORT procedures.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East & Africa

North America, comprising the US and Canada, accounted major share of the intraoperative radiation therapy market in 2019. The major factors driving market growth in this region are the easy availability and high adoption of IORT for cancer treatment, the rising incidence of cancer, and significant per capita annual healthcare expenditure in the US and Canada.  

Request for sample pages  @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083

Ambulatory Surgical Centers Market worth USD 7.2 billion : Key Industry Insights, Current And Future Perspectives

 [176 Pages Report] The Ambulatory surgical centers market is projected to reach USD 7.2 billion by 2025 from 2.1 billion in 2020, at a CAGR of 27.6% during the forecast period

The study involved four major activities in estimating the size of the Ambulatory Surgical Centers market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research.

Market Dynamics

• Increasing number of Ambulatory Surgical Centers
• Need to curtail escalating healthcare costs
• Growing use of IT solutions among ASCs
• Growing demand for cloud-based solutions
• Shift towards patient-centric healthcare delivery

Based on products and services, the Ambulatory surgical centers market is segmented into clinical solutions, non-clinical solutions, and HCIT outsourcing services. In 2019, the clinical solutions segment accounted for the largest share of the Ambulatory surgical centers market. The need to control the increasing healthcare costs and improve the efficiency of healthcare services by reducing medical errors are a major driver that propels the demand for healthcare provider solutions.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182183086

Based on components, the Ambulatory surgical centers market is segmented into services, software, and hardware. The services segment accounted for the largest market share in 2019. This is due to the introduction of complex software, the need for integration and interoperability of software, the growing demand for consulting and outsourcing of various healthcare processes such as revenue cycle management, EHR management, and fraud detection.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East & Africa

North America accounted for the largest share of the Ambulatory surgical centers market, followed by Europe. The large share of this region can be attributed to the high adoption of Ambulatory surgical centers for reducing the soaring healthcare costs, increasing volume of surgical procedures performed, and the presence of significant market players, such as Epic Systems Corporation (US), Cerner Corporation (US), McKesson Corporation (US), Philips Healthcare (Netherlands), and Allscripts Healthcare Solutions, Inc. (US).

Some key players mentioned in the research report are:

Cerner Corporation (US), McKesson Corporation (US), Allscripts Healthcare Solutions, Inc. (US), GE Healthcare (US), Philips Healthcare (Netherlands), athenahealth, Inc. (US), Optum (US), Epic Systems Corporation (US), Medical Information Technology, Inc. (MEDITECH) (US), eClinicalWorks (US), athenahealth, Inc. (US), Advanced Data Systems Corporation (US), NextGen Healthcare (US), CureMD (US), HST Pathways (US), and Surgical Information Systems (US).

Request for sample pages  @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=182183086

Dental Impression Systems Market worth USD 1.9 billion : Key Industry Insights, Current & Future Perspectives

 This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, key players, competitive landscape, key market dynamics, and key player strategies.

[171 Pages Report] The global dental impression systems market is projected to reach USD 1.9 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 7.7% during the forecast period

The growth in the dental impression systems market is mainly driven by factors such as the rising incidence of dental diseases, increasing demand for cosmetic dentistry. In addition, growing dental tourism in emerging markets and rising adoption of digital dentistry are expected to drive demand growth in the dental impression systems market during the forecast period.

Market Dynamics

• Rising incidence of dental diseases
• Dental caries and other periodontal diseases
• Increasing demand for cosmetic dentistry
• Growing dental tourism in emerging markets

Covid-19 Impact on the Dental impression systems Market

The current COVID-19 pandemic has resulted in a massive number of patients visiting healthcare facilities on a daily basis. As of December 2020, 63.8 million cases of COVID-19 have been reported across Africa, Asia Pacific, the Americas, Europe, and Oceania. The virus has resulted in approximately 1.5 million deaths. With the COVID-19 pandemic, most countries, including the whole of Europe, the US, India, and Australia, among others, are following complete nationwide lockdowns.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256609208 

Cosmetic dentistry is one of the fastest-growing segments in the dental industry. Several studies have estimated that the market for cosmetic dentistry will continue to grow at a rapid pace. With increasing disposable incomes, the willingness to undergo expensive cosmetic procedures has also increased among the population in various countries, specifically among the aging population.  

Some key players mentioned in the research report are:

The major players in the global dental impression systems market are 3M (US), Henry Schein (US), Dentsply Sirona (US), Mitsui Chemicals (Japan), and Envista (US). Other prominent players in this market include Parkell, Inc. (US), Kettenbach GmbH & Co. KG (Germany), Zest Dental Solutions (US), Keystone Industries (US), Ultradent Products, Inc. (US), Septodont Holding (US), GC Corporation (US), DETAX (Germany), Kerr Corporation (US), Ivoclar Vivadent (US), Kuraray Co. Ltd. (Japan), BEGO (Germany), Premier Dental Products Company (US), and DMG America (US).

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=256609208 

Genotyping Assay Market worth USD 31.9 billion : Analysis Of Worldwide Industry Trends And Opportunities

 The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing. The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years.  

MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate
( CAGR) of 22.0% during the forecast period.

Market Dynamics

1. Low Prices of Reprocessed Medical Devices2. Pressure to Reduce Volume of Regulated Medical Waste

The sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595 

The pharmaceutical and biopharmaceutical companies segment is expected to witness the highest growth during the forecast period. The increasing demand for pharmacogenomics in the drug discovery and development process and recommendations from the FDA to include genotyping and pharmacogenomics studies in the course of drug discovery have contributed to the growth of this market segment.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East and Africa

North America is expected to hold the largest market size in the global genotyping market during the forecast period, followed by the European region. The increasing adoption of technologically advanced genotyping products, the high healthcare expenditure, presence of advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, large number of genotyping-based R&D projects, and the presence of a large number of leading genotyping manufacturers in the region, along with an increasing demand from pharmaceutical companies for genotyping products and rising investments by government bodies, are responsible for the large share of the North American genotyping market.

Some key players mentioned in the research report are:

Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

Request for sample pages  @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595

Oncology Nutrition Market To Reach USD 2.21 Billion – Current Status, Growth Dynamics And Future Trends

 According to the new market research report “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood)“,published by MarketsandMarkets™, oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.

Expected Revenue Growth:

[92 Pages Report] The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.

Major Growth Drivers :

Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition formulas.

Accessories to Fuel the Growth of Oncology Nutrition Market

Factors such as shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the market growth.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967

Browse in-depth TOC on “Oncology Nutrition Market”

11– Tables23 – Figures92 – Pages

The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967

Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.